PMID: 3787535Jul 1, 1986

Influence of circulating alpha adrenoceptor agonists on lung function in patients with exercise induced asthma and healthy subjects

K LarssonP Hjemdahl


The influence of circulating noradrenaline (in this context primarily a non-selective alpha agonist) and the alpha 1 selective agonist phenylephrine on bronchial tone, blood pressure, and heart rate was studied in eight patients with exercise induced asthma and eight age and sex matched controls. All subjects refrained from taking treatment for at least one week before the trial. The agonists were infused intravenously in stepwise increasing doses of 0.04, 0.085, 0.17, and 0.34 micrograms/kg a minute for noradrenaline and 0.5, 1.0, 2.0, and 4.0 micrograms/kg a minute for phenylephrine. At the highest dose the plasma concentration of noradrenaline was about 30 nmol/l, resembling the concentrations found during intense exercise, and that of phenylephrine was about 400 nmol/l. Both agonists caused dose dependent and similar increases in blood pressure in the two groups. Despite clearcut cardiovascular effects (systolic and diastolic blood pressure increased by about 40-50/25-30 mm Hg), neither agonist altered lung function, as assessed by measurements of specific airway compliance (sGaw), peak expiratory flow (PEF), or end expiratory flow rate, in either group. It is concluded that circulating alpha agonists, whether alpha 1 selec...Continue Reading


Aug 1, 1978·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·M P Kneussl, J Richardson
Mar 22, 1979·The New England Journal of Medicine·W R HendersonM Kaliner
Nov 1, 1976·Journal of Applied Physiology·J Richardson, J Béland
Apr 1, 1972·British Journal of Diseases of the Chest·J GaddieK N Palmer
Nov 1, 1971·Psychosomatic Medicine·R F AnthraciteP H Knapp
Aug 1, 1967·The Journal of Allergy·R M SlyL Strick
Dec 1, 1981·The Journal of Allergy and Clinical Immunology·P J BarnesH Vickers
May 1, 1981·Thorax·P J BarnesC T Dollery
Jan 1, 1982·The Journal of Allergy and Clinical Immunology·P B Davis, P Lieberman
Oct 1, 1982·European Journal of Clinical Pharmacology·C G Löfdahl, N Svedmyr
Aug 21, 1980·The New England Journal of Medicine·P E Cryer
Jun 1, 1980·European Journal of Pediatrics·D ReinhardtF Wegner
Mar 1, 1982·Journal of the Autonomic Nervous System·J M Doidge, D G Satchell


Jan 1, 1990·Molecular Aspects of Medicine·P J Barnes
Jan 1, 1990·Pharmacology & Therapeutics·R G GoldieK M Lulich

Related Concepts

Airway Resistance
Bronchospasm, Exercise-Induced
Norepinephrine, (+, -)-Isomer
Phenylephrine Hydrochloride
Respiratory Function Tests

Related Feeds


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.